Part D drug definition

Part D drug has the meaning given such term in 42 CFR 423.100.

Examples of Part D drug in a sentence

  • If the national average premium (as determined by Medicare) increases, your penalty will increase.• Second, you will continue to pay a penalty every month for as long as you are enrolled in a plan that has Medicare Part D drug benefits, even if you change plans.• Third, if you are under 65 and currently receiving Medicare benefits, the Part D late enrollment penalty will reset when you turn 65.

  • Section 9, Part D drug coverage in special situations includes more information on your Part D coverage and Original Medicare.

  • If you enroll in a Medicare plan that includes Part D drug coverage, you may need these notices to show that you have maintained creditable coverage.

  • If the national average premium (as determined by Medicare) increases, your penalty will increase. Second, you will continue to pay a penalty every month for as long as you are enrolled in a plan that has Medicare Part D drug benefits, even if you change plans. Third, if you are under 65 and currently receiving Medicare benefits, the Part D late enrollment penalty will reset when you turn 65.

  • Section 1.2 Basic rules for the plan’s Part D drug coverageThe plan will generally cover your drugs as long as you follow these basic rules:● You must have a provider (a doctor, dentist or other prescriber) write your prescription.● Your prescriber must either accept Medicare or file documentation with CMS showing that he or she is qualified to write prescriptions, or your Part D claim will be denied.

  • There are three important things to note about this monthly Part D late enrollment penalty:• First, the penalty may change each year, because the average monthly premium can change each year.• Second, you will continue to pay a penalty every month for as long as you are enrolled in a plan that has Medicare Part D drug benefits, even if you change plans.• Third, if you are under 65 and currently receiving Medicare benefits, the Part D late enrollment penalty will reset when you turn 65.

  • To apply for Medicare, you can call Social Security or visit your local Social Security office.Social Security is also responsible for determining who has to pay an extra amount for their Part D drug coverage because they have a higher income.

  • If the national average premium (as determined by Medicare) increases, your penalty will increase.● Second, you will continue to pay a penalty every month for as long as you are enrolled in a plan that has Medicare Part D drug benefits, even if you change plans.● Third, if you are under 65 and currently receiving Medicare benefits, the Part D late enrollment penalty will reset when you turn65.

  • If the national average premium (as determined by Medicare) increases, your penalty will increase.· Second, you will continue to pay a penalty every month for as long as you are enrolled in a plan that has Medicare Part D drug benefits, even if you change plans.· Third, if you are under 65 and currently receiving Medicare benefits, the Part D late enrollment penalty will reset when you turn 65.

  • In addition, we have the right to pursue collection of these premium amounts you owe.If you are having trouble paying your premium on time, please contact Customer Service to see if we can direct you to programs that will help with your costs.If we end your membership because you did not pay your plan premium, you will have health coverage under Original Medicare.As long as you are receiving “Extra Help” with your prescription drug costs, you will continue to have Part D drug coverage.

Related to Part D drug

  • New drug means: (i) any drug, except a new animal drug or an animal feed bearing or containing

  • Legend drugs means any drugs which are required by state

  • Legend drug or "prescription drug" means any drug or device that has been determined to be unsafe for self- medication or any drug or device that bears or is required to bear the legend:

  • Covered drug means any prescription drug that:

  • New Drug Application means a new drug application in the United States for authorization to market a product, as defined in the applicable laws and regulations and submitted to the FDA.

  • Invalid Drug Test means the result of a drug test for an oral fluid specimen that contains an unidentified adulterant, or an unidentified substance, that has abnormal physical characteristics, or that has an endogenous substance at an abnormal concentration preventing the laboratory from completing or obtaining a valid drug test result.

  • FFDCA means the United States Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., as amended from time to time, together with any rules, regulations and requirements promulgated thereunder (including all additions, supplements, extensions, and modifications thereto).

  • cosmetic product means any substance or mixture intended to be placed in contact with the external parts of the human body (epi­ dermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, keeping them in good condition or correcting body odours;

  • FDCA shall have the meaning ascribed to such term in Section 3.1(hh).

  • Prescription drug means any drug required by federal law or regulation to be dispensed only

  • FD&C Act means the United States Federal Food, Drug and Cosmetic Act, as amended.

  • Brand Name Drug means a Prescription Drug that has been given a name by a manufacturer or distributor to distinguish it as produced or sold by a specific manufacturer or distributor and may be used and protected by a trademark.

  • Prescription drug order means an original or new order from a practitioner for drugs, drug-related devices or treatment for a human or animal, including orders issued through collaborative care agreements. Lawful prescriptions result from a valid practitioner-patient relationship, are intended to address a legitimate medical need, and fall within the prescribing practitioner's scope of professional practice;

  • Biologics License Application or “BLA” means an application requesting permission from the FDA to introduce, or deliver for introduction, a biological product into interstate commerce, or any similar application or submission for marketing authorization of a product filed with a Regulatory Authority to obtain Regulatory Approval for such product in a country or group of countries.

  • Nonprescription drug or "over-the-counter drug" means any

  • Drug abuse means any pattern of pathological use of drugs that causes impairment in social or occupational functioning, or that produces physiological dependency evidenced by physical tolerance or by physical symptoms when it is withdrawn.

  • Drug addiction means a disease characterized by a

  • Prescription drugs means drugs, medicine and controlled substances which by law can only be prescribed for human use by persons authorized by law.

  • Generic Drug means a Prescription Drug that is medically equivalent to a Brand Name Drug as determined by the FDA. It meets the same standards as a Brand Name Drug for purity, safety, strength and effectiveness and is manufactured and sold under its chemical, common, or official name.

  • Automated drug dispensing system means a mechanical or electronic system that performs

  • Nonprescription drugs means nonnarcotic medicines or drugs which may be sold without a prescription and are prepackaged and labeled for use by the consumer in accordance with the requirements of the statutes and regulations of this state and the federal government;

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.

  • MHLW means the Japanese Ministry of Health, Labour and Welfare, and any successor agency thereto.

  • Narcotic drug means any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:

  • Legal drug means any drug, including any prescription drug or over-the-counter drug, that has been legally obtained and that is not unlawfully sold or distributed.